Overview
A leading antihistamine product, widely prescribed for allergic rhinitis and urticaria, launched a digital awareness campaign aimed at strengthening visibility and recall among healthcare professionals (HCPs). The goal was to highlight the product’s clinically proven, non-sedating formulation that provides multi-symptom relief, ensuring better patient outcomes.
Methodology
The campaign was executed over a 3-month period (April–July 2025) through Hidoc’s proprietary medical learning platform, targeting doctors across India.
- Format: Weekly banner ads (one per week).
- Channels: Exclusively via Hidoc App and Web.
- Messaging: Focused on fast, multi-symptom allergy relief, non-drowsy efficacy, and clinical validation.
- Tracking Metrics: Reach, impressions, clicks, and click-through rate (CTR).
Results
- Reach: Over 120,000 doctors across India (including General Physicians, Consulting Physicians, ENT Specialists, and Chest Physicians).
- Impressions: 2.23 million total impressions.
- Clicks: 100,620 clicks recorded.
- CTR: Average 5% CTR, surpassing industry benchmarks, with a peak of 6% in the final week.
- Geographical Performance:
- Maharashtra – 24% of impressions
- Andhra Pradesh – 19%
- Tamil Nadu – 14%
Key Highlights
- Consistently high engagement across multiple doctor specializations.
- Strong geographic resonance in high-prescription states.
- Steady week-on-week performance with increasing traction by campaign end.
Conclusion
The campaign effectively enhanced awareness and reinforced recall among doctors nationwide. With 120,000+ HCPs reached, 2.2M+ impressions, and over 100K clicks, the initiative showcased the strength of targeted digital engagement in the healthcare sector. Its success underscores the value of structured, data-driven communication strategies for future HCP-focused campaigns.
